Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Pre-Market Trading 11-05 07:28:51 EST

0.0729

-0.0110

-13.11%

盘前0.0800

+0.0071+9.74%

07:02 EST

High0.0839	Low0.0728	Vol2.02M
Open0.0839	D1 Closing0.0839	Amplitude13.23%
Mkt Cap1.21M	Tradable Cap1.20M	Total Shares16.55M
T/O156.13K	T/O Rate12.28%	Tradable Shares16.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":0.0729,"timestamp":1730754000000,"preClose":0.0839,"halted":0,"volume":2024597,"hourTrading":{"tag":"盘前","latestPrice":0.08,"preClose":0.0729,"latestTime":"07:02 EST","volume":5824,"amount":466.10863936,"timestamp":1730808179972},"delay":0,"floatShares":16492700,"shares":16548100,"eps":-35.120564,"marketStatus":"Pre-Market Trading","change":-0.011,"latestTime":"11-05 07:28:51 EST","open":0.0839,"high":0.0839,"low":0.0728,"amount":156125.36019113,"amplitude":0.1323,"askPrice":0.09,"askSize":100,"bidPrice":0.0738,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-35.120564,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1730817000000},"marketStatusCode":1,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":0.0729,"preHourTrading":{"tag":"盘前","latestPrice":0.08,"preClose":0.0729,"latestTime":"07:02 EST","volume":5824,"amount":466.10863936,"timestamp":1730808179972},"postHourTrading":{"tag":"盘后","latestPrice":0.081,"preClose":0.0729,"latestTime":"19:54 EST","volume":51905,"amount":3912.381,"timestamp":1730768093071},"volumeRatio":1.3333829910702568},"requestUrl":"/m/hq/s/BJDX","defaultTab":"news","newsList":[{"id":"2447842635","title":"Bluejay Diagnostics Closes $8.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2447842635","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447842635?lang=en_us&edition=fundamental","pubTime":"2024-06-29 01:19","pubTimestamp":1719595156,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics  said it closed Friday an underwritten public offering of under 5.4 million common or prefunded units, with expected gross proceeds of roughly $8.8 million.Net proceeds will be used to repay $2.3 million in debt, finance clinical studies and other activities related to seeking US Food and Drugs Administration approval, and for general working capital, the company said.Bluejay Diagnostics' shares fell 6.8% in recent trading Friday.Price: 0.70, Change: -0.05, Percent Change: -6.80","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2447358936","title":"Bluejay Diagnostics Closes $8.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2447358936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2447358936?lang=en_us&edition=fundamental","pubTime":"2024-06-29 01:19","pubTimestamp":1719595156,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2446826626","title":"Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2446826626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446826626?lang=en_us&edition=fundamental","pubTime":"2024-06-28 23:32","pubTimestamp":1719588767,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240628:nTUA1JN5KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446829536","title":"Press Release: Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2446829536","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446829536?lang=en_us&edition=fundamental","pubTime":"2024-06-28 23:32","pubTimestamp":1719588720,"startTime":"0","endTime":"0","summary":"ACTON, Mass., June 28, 2024  -- Bluejay Diagnostics, Inc.  , a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $8.75 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 5,368,098 Common Units or Prefunded Units, each Unit consisting of one share of the Company's common stock  or one pre-funded warrant to purchase one share of Common Stock , two Class C warrants each to purchase one share of our common stock  and one Class D Warrant to purchase such number of shares of common stock as determined in the Class D Warrant . The purchase price of each Common Unit is $1.63, and the purchase price of each Prefunded Unit is $1.6299 . The Prefunded Warrants will be immediately exercisable a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446662325","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2446662325","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446662325?lang=en_us&edition=fundamental","pubTime":"2024-06-28 02:00","pubTimestamp":1719511200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BJDX","BK4082","GRDI","BK4595","BK4585","CLSK","BK4023","BK4139","BK4583","BK4588","TNXP"],"gpt_icon":0},{"id":"2446555218","title":"Bluejay Diagnostics Shares Hit 52-Week Low After Public Offering Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2446555218","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446555218?lang=en_us&edition=fundamental","pubTime":"2024-06-27 22:08","pubTimestamp":1719497280,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics shares were down 50% to 82 cents, a 52-week low, after an underwritten public offering priced with proceeds expected to be about $8.75 million.The stock closed Wednesday's session down 41%, and is now down 97% in the past 12 months.The medical technology company said the base offering consists of 5.37 million units or prefunded units.Each unit consists of one share of Bluejay stock or one pre-funded warrant, two class C warrants and one class D warrant. The purchase price of each unit was $1.63.The closing of the offering is expected to occur Friday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446882530","title":"Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2446882530","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446882530?lang=en_us&edition=fundamental","pubTime":"2024-06-27 21:14","pubTimestamp":1719494072,"startTime":"0","endTime":"0","summary":"US stocks look set to open marginally lower in Thursday's trading session as investors parse relatively bullish economic data that came out earlier this morning, including Q1 GDP growth, weekly jobles","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SING","VIGL","BOF","BJDX","BK4211","RXRX","TNXP","BK4588","BK4583","BK4539","BK4096","BK4585","BK4212","BK4139","BK4189","SNY","IMMP","IONM","BK4548","BK4007","NLSP","BK4196","BK4082","ISBC","CASI"],"gpt_icon":0},{"id":"2446530327","title":"Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2446530327","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446530327?lang=en_us&edition=fundamental","pubTime":"2024-06-27 21:14","pubTimestamp":1719494072,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["QID","VIGL","NLSP","IVV","NQmain",".SPX","QLD","SNY","SPXU",".DJI","ESmain","SQQQ","TNXP","JMImain","CAC","NKmain","IONM","PSQ","DOG","NDAQ","QQQ","UPRO","MNQmain","CASI","OEX","SH","TQQQ","RXRX","SING","BJDX","NIYmain","DDM","DJX",".UKX.UK","SDOW","SDS",".IXIC","BOF","CID","SSO","UDOW","DAX","DXD","OEF","VOO","5IC.SI","SPY","IMMP","ISBC","JNImain"],"gpt_icon":0},{"id":"2446537373","title":"BRIEF-Bluejay Diagnostics Announces Pricing Of $8.75 Mln Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2446537373","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446537373?lang=en_us&edition=fundamental","pubTime":"2024-06-27 21:02","pubTimestamp":1719493376,"startTime":"0","endTime":"0","summary":"June 27 (Reuters) - Bluejay Diagnostics Inc   :   * BLUEJAY DIAGNOSTICS ANNOUNCES PRICING OF $8.75 MILLION UNDERWRITTEN PUBLIC OFFERINGSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446653228","title":"Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2446653228","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446653228?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:58","pubTimestamp":1719493081,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240627:nTUA5MMB42:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2446379995","title":"Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2446379995","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446379995?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:58","pubTimestamp":1719493080,"startTime":"0","endTime":"0","summary":"ACTON, Mass., June  27, 2024  (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc.(NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platfo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/27/2905221/0/en/Bluejay-Diagnostics-Announces-Pricing-of-8-75-Million-Underwritten-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446539414","title":"US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2446539414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446539414?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:12","pubTimestamp":1719490364,"startTime":"0","endTime":"0","summary":"US stock futures were trending slightly lower in Thursday's premarket activity ahead of a slew of economic data coming out this morning, including Q1 GDP growth, weekly jobless claims, and durable goo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4211","CASI","IONM","ISBC","BJDX","BK4082","BK4588","TNXP","BK4189","BK4583","BOF","SNY","BK4585","BK4196","VIGL","BK4007","BK4212"],"gpt_icon":0},{"id":"2446397585","title":"US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2446397585","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446397585?lang=en_us&edition=fundamental","pubTime":"2024-06-27 20:12","pubTimestamp":1719490364,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["ISBC","UDOW","QLD","UPRO","BK4534","DOG","DXD","OEF","BJDX","CID","IONM","LU2095319765.USD","SSO","BK4082","SPXU","DDM","LU2210150020.SGD","BK4196","BK4211","QID","BK4550",".SPX","SDOW","BOF","SPY","BK4189","SNY","SDS","SH","TNXP","NDAQ","BK4559","NQmain","OEX","VOO","LU2210149790.SGD","ESmain","CASI","PSQ","IVV","TQQQ","MNQmain",".IXIC","QQQ","SQQQ","BK4585","DJX","VIGL",".DJI","BK4112"],"gpt_icon":0},{"id":"2446395367","title":"Bluejay Diagnostics Sees Positive Trial Results for Interleukin-6","url":"https://stock-news.laohu8.com/highlight/detail?id=2446395367","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446395367?lang=en_us&edition=fundamental","pubTime":"2024-06-26 20:19","pubTimestamp":1719404340,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics said it saw positive results from the primary analysis of a clinical study investigating the role of interleukin-6 in patients diagnosed with sepsis and septic shock.The company said the primary analysis of the study showed that IL-6 levels within 24 hours of sepsis or septic shock diagnosis and admission to the intensive care unit may predict patient mortality out to 28 days.A secondary outcome of the study showed that IL-6 levels within 24 hours of sepsis or septic shock diagnosis and admission to the ICU is a predictor of patient mortality during their hospitalization. Other secondary outcomes showed that lactate and sequential organ failure assessment, standard clinical tests used for sepsis and septic shock patients, weren't predictors of patient mortality out to 28 days.Bluejay Diagnostics is planning to begin its next clinical study in the third quarter of 2024. If the results are positive, the company intends to use the study as support in a 510 application ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2446832362","title":"SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2446832362","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446832362?lang=en_us&edition=fundamental","pubTime":"2024-06-26 20:00","pubTimestamp":1719403200,"startTime":"0","endTime":"0","summary":"Results from primary analysis of the SYMON-I pilot clinical study consistent with IL-6 as a predictor of patients who have a mortality event with 28 days after sepsis and septic shock diagnosis and ar","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/26/2904444/0/en/SYMON-I-Study-of-Symphony-IL-6-Suggests-Prediction-of-Mortality-in-Sepsis-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU","BJDX","BK4082"],"gpt_icon":0},{"id":"2444167109","title":"Bluejay Diagnostics announces 1-for-8 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2444167109","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444167109?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:43","pubTimestamp":1718628224,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics  announced that the company’s Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-8.The Reverse Stock Split will become effective at 12:01 a.m. ETon June 20, 2024, and the company’s common stock will open for trading on The Nasdaq Capital Market on a post-split basis on June 20, 2024 under the company’s existing trading symbol, “BJDX.”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4116615-bluejay-diagnostics-announces-1-for-8-reverse-stock-split","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":[".IXIC","MNQmain","TQQQ","BK4082","BJDX","NQmain","QQQ","PSQ","SQQQ","QLD","QID"],"gpt_icon":1},{"id":"2444662651","title":"BRIEF-Bluejay Diagnostics Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2444662651","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444662651?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:05","pubTimestamp":1718625923,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Inc   :   * BLUEJAY DIAGNOSTICS ANNOUNCES REVERSE STOCK SPLIT   * BLUEJAY ANNOUNCES 1-FOR-8 REVERSE STOCK SPLITSource text for Eikon:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2444166654","title":"Bluejay Diagnostics Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2444166654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444166654?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:00","pubTimestamp":1718625601,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Announces Reverse Stock Split","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240617:nTUA3QDQ08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"gpt_icon":0},{"id":"2444166150","title":"Bluejay Announces 1-for-8 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2444166150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444166150?lang=en_us&edition=fundamental","pubTime":"2024-06-17 20:00","pubTimestamp":1718625601,"startTime":"0","endTime":"0","summary":"Bluejay Announces 1-for-8 Reverse Stock Split","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240617:nTUA3QDQ08:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"gpt_icon":0},{"id":"2437037600","title":"BJDX: 1Q:24 Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2437037600","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2437037600?lang=en_us&edition=fundamental","pubTime":"2024-05-24 17:00","pubTimestamp":1716541200,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics, Inc.  reported first quarter 2024 operational and financial results in a Form 10-Q on May 15th, 2024. Pilot study SYMON-I is underway and has completed enrollment, with 143 subjects entering the trial. Based on the recruitment information in SYMON-I’s clincaltrials.gov entry and management commentary, we expect the final data collection to be complete before the end of May and study completion in June.Bluejay is targeting a major scientific conference to share its data; however, the company is also cognizant that a capital raise must be completed and investors will want to see the data. Based on the limited narrative provided in the most recent quarterly filing, the initial look at data suggests it is positive and supportive of the primary endpoint.Bluejay generated no revenues in 1Q:24 and reported a net loss of  million, or  per share. For the quarter ending March 31st, 2024, and versus the same period in the prior year:. Bluejay initially launched a trial that s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bjdx-1q-24-financial-090000658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BJDX","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":-0.3116},{"period":"1month","weight":-0.4568},{"period":"3month","weight":-0.831},{"period":"6month","weight":-0.9825},{"period":"1year","weight":-0.9975},{"period":"ytd","weight":-0.9925}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.190287},{"month":2,"riseRate":0.333333,"avgChangeRate":0.056063},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.096888},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.204848},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.071091},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.243957},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.009947},{"month":8,"riseRate":0,"avgChangeRate":-0.261385},{"month":9,"riseRate":0,"avgChangeRate":-0.274525},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.152334},{"month":11,"riseRate":0,"avgChangeRate":-0.134478},{"month":12,"riseRate":0,"avgChangeRate":-0.390543}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction